Three-week Course of Radiation Safe and Effective for Patients with Early-stage Breast Cancer and Elevated Risk of Recurrence

Randomized trial finds hypofractionated whole-breast radiation with concurrent boost comparable to six weeks of treatment for patients with higher-risk disease

Related Keywords

Japan ,United States ,Hong Kong ,United Kingdom ,Israel ,Singapore ,Canada ,South Korea ,Switzerland ,Republic Of Korea ,Franka Vicini , ,American Society For Radiation Oncology ,Research Breast Care Services At Genesiscare ,American Society ,Radiation Oncology ,National Director ,Breast Care Services ,